deltatrials
Unknown OBSERVATIONAL NCT05156086

Safety and Effectiveness of COVID-19 Vaccine in Kidney Transplant Recipients (CoVaKT)

Prospective Study on the Safety and Effectiveness of COVID-19 Vaccine in Kidney Transplant Recipients

Sponsor: Seoul National University Hospital

Conditions COVID-19 Vaccination Renal Transplant
Interventions COVID-19 vaccine, booster
Updated 5 times since 2022 Last updated: Dec 14, 2021 Started: Nov 16, 2021 Primary completion: Aug 1, 2022 Completion: Nov 8, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on COVID-19 Vaccination and Renal Transplant, this trial is ongoing. The trial is conducted by Seoul National University Hospital and has accumulated 5 data snapshots since 2021. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

~Jan 2022 – ~Jan 2024 · 24 months · monthly snapshotRecruiting~Jan 2024 – ~Jul 2024 · 6 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotUnknown~Sep 2025 – present · 10 months · monthly snapshotUnknown

Change History

5 versions recorded

  1. Sep 2025 — Present [monthly]

    Unknown

  2. Sep 2024 — Sep 2025 [monthly]

    Unknown

  3. Jul 2024 — Sep 2024 [monthly]

    Unknown

    Status: Unknown Status → Unknown

  4. Jan 2024 — Jul 2024 [monthly]

    Unknown Status

    Status: Recruiting → Unknown Status

  5. Jan 2022 — Jan 2024 [monthly]

    Recruiting

    First recorded

Nov 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Seoul National University Hospital
Data source: Seoul National University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations